Neos Therapeutics Resubmits NDA for FDA Review of Amphetamine Extended-Release Orally Disintegrating Tablets to Treat ADHD
July 30, 2015 at 07:11 AM EDT
Neos Therapeutics, Inc. (NASDAQ: NEOS today announced that it has resubmitted a New Drug Application ("NDA") to the ...